Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (751-760 of 1,253) with videos related to

Pageof 126
Sort By:
Heart (British Cardiac Society)|January 21, 2018
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve diseaseDragos Vinereanu, Alice Wang, Hillary Mulder, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastomaY Licón-Muñoz, V Avalos, S Subramanian, et al.
The Canadian Journal of Cardiology|June 20, 2020
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery DiseaseGuillaume Marquis-Gravel, Shamir R Mehta, Marco Valgimigli, et al.
Journal of the American College of Cardiology|June 15, 2004
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionRichard E Waters, Kanwar P Singh, Matthew T Roe, et al.
American Heart Journal|December 3, 2014
How can we optimize the processes of care for acute coronary syndromes to improve outcomes?Lars Wallentin, Steen Dalby Kristensen, Jeffrey L Anderson, et al.
Journal of the American College of Cardiology|November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesM G Cohen, C B Granger, E M Ohman, et al.
Circulation|March 13, 2020
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney DiseaseJohn W Stanifer, Sean D Pokorney, Glenn M Chertow, et al.
Indian Heart Journal|April 13, 2017
Reducing system delays in treatment of ST elevation myocardial infarction and confronting the challenges of late presentation in low and middle-income countriesSameer Mehta, Christopher B Granger, Timothy D Henry, et al.
European Heart Journal|November 16, 2022
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillationZiad Hijazi, Alexander P Benz, Johan Lindbäck, et al.
European Heart Journal|June 9, 2009
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trialRenato D Lopes, Laine E Elliott, Harvey D White, et al.
Pageof 126

Showing results (751-760 of 1,253) with videos related to

Sort By:
Pageof 126
Heart (British Cardiac Society)|January 21, 2018
Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve diseaseDragos Vinereanu, Alice Wang, Hillary Mulder, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastomaY Licón-Muñoz, V Avalos, S Subramanian, et al.
The Canadian Journal of Cardiology|June 20, 2020
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery DiseaseGuillaume Marquis-Gravel, Shamir R Mehta, Marco Valgimigli, et al.
Journal of the American College of Cardiology|June 15, 2004
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionRichard E Waters, Kanwar P Singh, Matthew T Roe, et al.
American Heart Journal|December 3, 2014
How can we optimize the processes of care for acute coronary syndromes to improve outcomes?Lars Wallentin, Steen Dalby Kristensen, Jeffrey L Anderson, et al.
Journal of the American College of Cardiology|November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesM G Cohen, C B Granger, E M Ohman, et al.
Circulation|March 13, 2020
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney DiseaseJohn W Stanifer, Sean D Pokorney, Glenn M Chertow, et al.
Indian Heart Journal|April 13, 2017
Reducing system delays in treatment of ST elevation myocardial infarction and confronting the challenges of late presentation in low and middle-income countriesSameer Mehta, Christopher B Granger, Timothy D Henry, et al.
European Heart Journal|November 16, 2022
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillationZiad Hijazi, Alexander P Benz, Johan Lindbäck, et al.
European Heart Journal|June 9, 2009
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trialRenato D Lopes, Laine E Elliott, Harvey D White, et al.
Pageof 126